Lastly, BRIP1, which interacts with and is necessary for the function of BRCA1, is a tumour suppressor, and loss-of-function germline mutations increase the risk of breast and ovarian cancers [74, 75]. This evidence concerns the gene BRCA1 and ovarian cancer.